We are live on ! Find out more
BI

BVF Inc Portfolio holdings

AUM $3.91B
1-Year Est. Return 304.52%
This Fund
S&P 500
This Quarter Est. Return
-2.94%
1 Year Est. Return
+304.52%
3 Year Est. Return
+591.72%
5 Year Est. Return
+1,391.92%
10 Year Est. Return
+28,184.58%
AUM
$2.56B
AUM Growth
-$105M
Cap. Flow
+$19.4M
Cap. Flow %
0.76%
Top 10 Hldgs %
48.1%
Holding
79
New
9
Increased
20
Reduced
11
Closed
4

Top Buys

Rank Stock Value
1
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$66.5M
2
AMRN
Amarin Corp
AMRN
+$47.6M
3
WHWK
Whitehawk Therapeutics
WHWK
+$35M
4
TYRA icon
Tyra Biosciences
TYRA
+$32.4M
5
KYMR icon
Kymera Therapeutics
KYMR
+$31.9M

Top Sells

Rank Stock Value
1
MRUS
Merus
MRUS
+$156M
2
ARGX icon
argenx
ARGX
+$90.3M
3
RLAY icon
Relay Therapeutics
RLAY
+$29.9M
4
FBRX
Forte Biosciences
FBRX
+$19.9M
5
IMVT icon
Immunovant
IMVT
+$13.5M

Sector Composition

Rank Sector Weight
1 Healthcare 94.78%
2 Miscellaneous 4.73%
3 Financials 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
76
DELISTED
Centessa Pharmaceuticals
CNTA
– –
-58,900
Closed -$1.31M
FBRX
77
DELISTED
Forte Biosciences
FBRX
– –
-23,672
Closed -$19.9M
IMVT icon
78
Immunovant
IMVT
$7.51B
– –
-1,273,516
Closed -$13.5M
MRUS
79
DELISTED
Merus
MRUS
– –
-7,285,071
Closed -$156M
1 2 3
4

Similar funds

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.91B AUM 14.77% 1-Year Est. Return
GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.91B AUM
FFGIM
Founders Fund Growth II Management San Francisco, California $3.9B AUM
AIM
ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

BVF Inc's Q3 2021 Portfolio in Review

As of Q3 2021, BVF Inc held 79 positions worth $2.56B, down 3.9% from $2.67B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

BVF Inc's Q3 2021 filing shows 9 new, 20 increased, 11 reduced and 4 closed positions. Its largest new stake was Lakefront Biotherapeutics American Depositary Shares: 1,119,733 shares worth $58.9M. The largest sale was Merus, an estimated $156M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 99% a quarter earlier, followed by Miscellaneous and Financials.

  • BVF Inc's largest Q3 2021 buy was Lakefront Biotherapeutics American Depositary Shares: 1,119,733 shares worth $58.9M.
  • BVF Inc added most to Amarin Corp in Q3 2021, an estimated $47.6M increase.
  • BVF Inc's biggest Q3 2021 reduction was argenx, cutting an estimated $90.3M.
  • BVF Inc fully exited Merus in Q3 2021, selling an estimated $156M.
  • BVF Inc's ten largest holdings make up 48% of its $2.56B portfolio in Q3 2021.
  • BVF Inc opened 9 new positions and closed 4 in Q3 2021.
  • BVF Inc's portfolio value fell 3.9% quarter-over-quarter to $2.56B.

Based on BVF Inc's 13F filing for Q3 2021, filed 15 Nov 2021.